Skip to content
Clinical Trials – home
AustriaBack to Austria

Clinical trials in Sankt Veit Im Pongau

20 clinical trials in Sankt Veit Im Pongau, Austria. Every trial is listed in the EU Clinical Trials Register and updated daily.

Sankt Veit Im Pongau at a glance
20
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

20 trials in Sankt Veit Im Pongau

Open in trial search

Study on Managing Heart Attack Risk with Icosapent Ethyl and Drug Combination for Patients at High Risk of Another Heart Attack

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Colchicine
  • Sponsor:Medical University Of Graz

Study on the Effectiveness of PQ Grass for Children and Teens with Seasonal Allergies from Grass Pollen

Registered drug
Countries:BulgariaBulgaria
  • Participants:0–17 years
  • Substances:Desloratadine
  • Sponsor:Allergy Therapeutics (UK) Limited

Study of drug combinations including cisplatin, carboplatin, doxorubicin, fluorouracil, vincristine, etoposide, irinotecan, gemcitabine, oxaliplatin and sorafenib for children with hepatoblastoma or hepatocellular carcinoma

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:0–17 years · 18–64 years
  • Substances:Carboplatin
  • Sponsor:The University Of Birmingham

Safety of PF-07872412 versus 20‑valent pneumococcal conjugate vaccine in healthy infants for prevention of pneumococcal disease

Registered drugNo placebo
Countries:FinlandFinland
  • Participants:0–17 years
  • Substances:PF-07831695
  • Sponsor:Pfizer Inc.

Myasthenia gravis

Not yet recruiting

Efficacy and Safety of DNTH103 in Adults with Generalized Myasthenia Gravis: A Phase 3 Randomized, Double‑Blind, Placebo‑Controlled Study

Investigational
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:DNTH103
  • Sponsor:Dianthus Therapeutics Inc.

Varicella+5

Not yet recruiting

Immune response and safety of investigational MMRV vaccine (GSKVX000000025896) drug combination compared with standard MMRV vaccine in healthy children 15 months to 6 years

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:0–17 years · Healthy volunteers
  • Substances:GSKVX000000025896
  • Sponsor:GlaxoSmithKline Biologicals

Comparison of dupilumab and tezepelumab for the treatment of chronic rhinosinusitis with nasal polyps.

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Dupilumab
  • Sponsor:Medical University Of Vienna

Type 2 diabetes mellitus

Not yet recruiting

Comparison of weekly insulin icodec versus daily basal insulin in adults with type 2 diabetes who have not used insulin before

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Insulin degludec
  • Sponsor:Novo Nordisk A/S

Ischaemic stroke+2

Not recruiting

Study on Asundexian for Preventing Ischemic Stroke in Adults After a Stroke or High-Risk Mini-Stroke

Investigational
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Asundexian
  • Sponsor:Bayer AG

Study on OM-85 for Preventing Respiratory Infections in Children with Wheezing Illness (Ages 6 Months to 5 Years)

Registered drug
Countries:GermanyGermany
  • Participants:0–17 years
  • Sponsor:OM Pharma SA

Study on the Safety and Immune Response of a Booster Dose of MenACYW Conjugate Vaccine in Children and Adolescents Previously Vaccinated for Meningococcal Infection

Registered drugNo placebo
Countries:FinlandFinland
  • Participants:0–17 years · Healthy volunteers
  • Substances:Tetanus toxoid
  • Sponsor:Sanofi Winthrop Industrie

Tonsillitis

Not recruiting

Study on Ropivacaine and Lidocaine for Reducing Pain After Tonsil Removal in Patients with Chronic Tonsillitis

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Diclofenac Sodium
  • Sponsor:Tauernkliniken GmbH

Other cities in Austria

The busiest research cities in the country

All 48 cities in Austria

Clinical research in Sankt Veit Im Pongau

What the registry says about research in the country

01 Pediatric Liver Cancer Research

Comprehensive clinical research focusing on hepatoblastoma and hepatocellular carcinoma in pediatric patients, evaluating various treatment approaches based on risk stratification.

  • Very Low-Risk and Low-Risk Studies
  • Intermediate Risk Treatments
  • High-Risk Management Protocols

The trials aim to optimize treatment strategies while collecting valuable biological and toxicity data to enhance patient outcomes.

02 Advanced Therapeutic Combinations

Investigation of multiple chemotherapy combinations including cisplatin-based regimens and innovative drug combinations for treating pediatric liver tumors.

  • Standard vs. Modified Protocols
  • Novel Drug Combinations
  • Risk-Adapted Approaches

Research focuses on comparing treatment efficacy and toxicity profiles across different therapeutic strategies.

03 Targeted Treatment Research

Evaluation of targeted therapies including specific protocols for resected and unresected liver cancers in pediatric patients.

  • Post-Surgery Protocols
  • Metastatic Disease Management
  • Combination Therapy Assessment

Studies examine the effectiveness of various treatment combinations and their timing in different patient groups.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.